126 related articles for article (PubMed ID: 30737563)
1. Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CT.
Pattison DA; MacFarlane LL; Callahan J; Kane EL; Akhurst T; Hicks RJ
EJNMMI Res; 2019 Feb; 9(1):15. PubMed ID: 30737563
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Computer simulations suggest that acute correction of hyperglycaemia with an insulin bolus protocol might be useful in brain FDG PET.
Buchert R; Santer R; Brenner W; Apostolova I; Mester J; Clausen M; Silverman DH
Nuklearmedizin; 2009; 48(1):44-54. PubMed ID: 19212611
[TBL] [Abstract][Full Text] [Related]
4. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT.
Büsing KA; Schönberg SO; Brade J; Wasser K
Nucl Med Biol; 2013 Feb; 40(2):206-13. PubMed ID: 23228852
[TBL] [Abstract][Full Text] [Related]
5. Influence of subcutaneous administration of rapid-acting insulin in the quality of (18)F-FDG PET/CT studies.
Garcia JR; Sanchis A; Juan J; Tomas J; Domenech A; Soler M; Moragas M; Riera E
Nucl Med Commun; 2014 May; 35(5):459-65. PubMed ID: 24535382
[TBL] [Abstract][Full Text] [Related]
6. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients.
Roy FN; Beaulieu S; Boucher L; Bourdeau I; Cohade C
J Nucl Med; 2009 Feb; 50(2):178-83. PubMed ID: 19164226
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of the pregnancy-IVI, an intravenous insulin protocol for pregnancy, following antenatal betamethasone in type 1 and type 2 diabetes.
Rowe CW; Watkins B; Brown K; Delbridge M; Addley J; Woods A; Wynne K
Diabet Med; 2021 Apr; 38(4):e14489. PubMed ID: 33277738
[TBL] [Abstract][Full Text] [Related]
8. Effects of hyperglycemia on fluorine-18-fluorodeoxyglucose biodistribution in a large oncology clinical practice.
Rosica D; Cheng SC; Hudson M; Sakellis C; Van den Abbeele AD; Kim CK; Jacene HA
Nucl Med Commun; 2018 May; 39(5):417-422. PubMed ID: 29629997
[TBL] [Abstract][Full Text] [Related]
9. An intravenous insulin protocol designed for pregnancy reduces neonatal hypoglycaemia following betamethasone administration in women with gestational diabetes.
Rowe CW; Putt E; Brentnall O; Gebuehr A; Allabyrne J; Woods A; Wynne K
Diabet Med; 2019 Feb; 36(2):228-236. PubMed ID: 30443983
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDGPET/CT: diabetes and hyperglycaemia.
Niccoli-Asabella A; Iuele FI; Merenda N; Pisani AR; Notaristefano A; Rubini G
Nucl Med Rev Cent East Eur; 2013; 16(2):57-61. PubMed ID: 24068633
[TBL] [Abstract][Full Text] [Related]
11. Ultrashort-acting insulin may improve on 18F-FDG PET/CT image quality in patients with uncontrolled diabetic mellitus.
Song HS; Yoon JK; Lee SJ; Yoon SH; Jo KS; An YS
Nucl Med Commun; 2013 Jun; 34(6):527-32. PubMed ID: 23511925
[TBL] [Abstract][Full Text] [Related]
12. Proposal for an optimized protocol for intravenous administration of insulin in diabetic patients undergoing (18)F-FDG PET/CT.
Caobelli F; Pizzocaro C; Paghera B; Guerra UP
Nucl Med Commun; 2013 Mar; 34(3):271-5. PubMed ID: 23250295
[TBL] [Abstract][Full Text] [Related]
13. Effect of blood glucose level on standardized uptake value (SUV) in
Eskian M; Alavi A; Khorasanizadeh M; Viglianti BL; Jacobsson H; Barwick TD; Meysamie A; Yi SK; Iwano S; Bybel B; Caobelli F; Lococo F; Gea J; Sancho-Muñoz A; Schildt J; Tatcı E; Lapa C; Keramida G; Peters M; Boktor RR; John J; Pitman AG; Mazurek T; Rezaei N
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):224-237. PubMed ID: 30350009
[TBL] [Abstract][Full Text] [Related]
14. Assessing oral glucose and intravenous insulin loading protocol in
Sarikaya I; Sharma PN; Sarikaya A; Elgazzar AH
World J Nucl Med; 2020; 19(1):1-7. PubMed ID: 32190015
[TBL] [Abstract][Full Text] [Related]
15. In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.
Cochran BJ; Ryder WJ; Parmar A; Tang S; Reilhac A; Arthur A; Charil A; Hamze H; Barter PJ; Kritharides L; Meikle SR; Gregoire MC; Rye KA
Diabetologia; 2016 Sep; 59(9):1977-84. PubMed ID: 27193916
[TBL] [Abstract][Full Text] [Related]
16. Treatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study.
Radhakutty A; Stranks JL; Mangelsdorf BL; Drake SM; Roberts GW; Zimmermann AT; Stranks SN; Thompson CH; Burt MG
Diabetes Obes Metab; 2017 Apr; 19(4):571-578. PubMed ID: 27995731
[TBL] [Abstract][Full Text] [Related]
17. Utility of Short-Acting Intravenous Insulin Therapy in Preparation of F-18 Fluorodeoxyglucose Positron Emission Tomography Computed Tomography Scan in Cancer Patients Incidentally Detected with High Blood Glucose Levels on the Day of Test.
Rallapeta RP; Manthri RG; Kalawat T; Sachan A; Lakshmi AY; Hulikal N
Indian J Nucl Med; 2020; 35(2):110-115. PubMed ID: 32351264
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy of
Lemans JVC; Hobbelink MGG; IJpma FFA; Plate JDJ; van den Kieboom J; Bosch P; Leenen LPH; Kruyt MC; Glaudemans AWJM; Govaert GAM
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):999-1008. PubMed ID: 30523391
[TBL] [Abstract][Full Text] [Related]
19. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-D: -glucose Injection following I.V. Insulin in diabetic patients.
Turcotte E; Leblanc M; Carpentier A; Bénard F
Mol Imaging Biol; 2006; 8(6):348-54. PubMed ID: 17053859
[TBL] [Abstract][Full Text] [Related]
20. A retrospective audit of insulin infusion management involving a locally developed dynamic insulin infusion guideline in a tertiary ICU.
Breeding J; Welch S; Buscher H; Nair P; Frost C; Newman S; Whittam S
Aust Crit Care; 2015 Aug; 28(3):149-59. PubMed ID: 25092627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
